default author photo

Minfeng Zhang

Government of the People's Republic of China - Department of Hepatic Surgery I (Ward I)

Shanghai

China

Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation

255 Changhai Road

Shanhai, 200438

China

SCHOLARLY PAPERS

3

DOWNLOADS

172

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

A Risk Scoring System for Predicting Overall Survival in Patients with Liver Cancer

Number of pages: 25 Posted: 21 Jul 2020
Government of the People's Republic of China - Department of Hepatic Surgery I (Ward I), Genecast Precision Medicine Technology Institute, Genecast Precision Medicine Technology Institute, Government of the People's Republic of China - Department of Hepatic Surgery I (Ward I), Government of the People's Republic of China - Department of Hepatic Surgery I (Ward I), Government of the People's Republic of China - Department of Hepatic Surgery VI, Government of the People's Republic of China - Department of Hepatic Surgery VI, Government of the People's Republic of China - Department of Hepatic Surgery VI, Genecast Precision Medicine Technology Institute, Capital Medical University - Institute of Infectious Diseases, Genecast Precision Medicine Technology Institute, Genecast Precision Medicine Technology Institute, Government of the People's Republic of China - Department of Hepatic Surgery VI and Capital Medical University - Institute of Infectious Diseases
Downloads 65 (916,100)

Abstract:

Loading...

Hepatocellular carcinoma, prognosis, machine learning, multiplex immunohistochemistry, tumor microenvironment

2.

LncRNA FOXD2-AS1 as a Competitive Endogenous RNA against miR-150-5p Reverses Resistance to Sorafenib in Hepatocellular Carcinoma

Number of pages: 24 Posted: 30 Jan 2019
Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation, Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation, Nanjing Medical University, Government of the People's Republic of China - Department of Hepatic Surgery I (Ward I), Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation, Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation, Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation, Government of the People's Republic of China - Department of Special Treatment and Liver Transplantation and Eastern Hepatobiliary Surgery Hospital, Department of Special Treatment and Liver Transplantation
Downloads 58 (980,173)

Abstract:

Loading...

long non-coding RNA (lncRNA), hepatocellular carcinoma (HCC), sorafenib, resistance, proliferation, pathogenesis

3.

The CD68+ Macrophages to CD8+ T-Cell Ratio Is Associated with Clinical Outcomes in Hepatocellular Carcinoma

Number of pages: 30 Posted: 11 Sep 2019
Government of the People's Republic of China - Department of Hepatic Surgery I (Ward I), Genecast Precision Medicine Technology Institute, Fudan University - Huashan Hospital, Government of the People's Republic of China - Department of Hepatic Surgery I (Ward I), Government of the People's Republic of China - Department of Hepatic Surgery I (Ward I), Government of the People's Republic of China - Department of Hepatic Surgery VI, Government of the People's Republic of China - Department of Hepatic Surgery VI, Government of the People's Republic of China - Department of Hepatic Surgery VI, Genecast Precision Medicine Technology Institute, Genecast Precision Medicine Technology Institute, Genecast Precision Medicine Technology Institute, Genecast Precision Medicine Technology Institute, Genecast Precision Medicine Technology Institute, Genecast Precision Medicine Technology Institute, Capital Medical University - Institute of Infectious Diseases, Tongji University - Shanghai Tenth People's Hospital and Government of the People's Republic of China - Department of Hepatic Surgery VI
Downloads 49 (1,074,648)

Abstract:

Loading...

macrophage; T-cell; hepatocellular carcinoma; prognosis; multiplex immunohistochemistry